|
|||||
|
Careers At Navanti Group
DEVELOP YOUR CAREER Do really interesting work Have a voice We honor drive and excellence Be creative Interested in applying for a position, but don't see one that fits right now? Submit your resume for future consideration here. Navanti provides equal employment opportunities (EEO) to all employees and qualified applicants for employment without regard to race, color, religion, gender, gender identity, sexual orientation, ancestry, national or ethnic origin, age, marital status, handicap, disability, or status as a Veteran. We do not tolerate discrimination in any form and take measures to prevent discrimination against any employee or job applicant. We have a zero-tolerance policy for sexual harassment, exploitation, and/or abuse of power. If you would like more information about your EEO rights as an applicant under US law, please click here. Malaria and Maternal, Newborn, and Child Health (MNCH) Expert - Drug Revolving Fund Activity Evaluation
Title: Malaria and Maternal, Newborn, and Child Health (MNCH) Expert Team: USAID/Nigeria MEL Support Activity Project: USAID/Nigeria Health Population and Nutrition (HPN) Office Location: Federal Capital Territory – Abuja, Nigeria Reporting to: Assessment and Evaluation Advisor Employment Type: Independent Contractor / Short-Term Technical Assistance (STTA) Period of Performance: July 2024 – November 2024 Number of Positions: 1
Navanti supports a Monitoring, Evaluation, and Learning (MEL) Support Activity program that assists USAID/Nigeria in advancing its broader organizational learning and development efforts. This program strengthens the Mission’s capacity and performance in programmatic monitoring, evaluation, learning, collaborating, and adapting. The MEL Support Activity closely aligns with USAID/Nigeria’s Country Development Cooperation Strategy (CDCS). It provides a broad range of specialized technical assistance, training, data gathering and analysis, field-based monitoring, evaluations and assessments, facilitation of organizational learning and adaptation initiatives, and short-term technical assistance.
Overview and Evaluation Purpose: USAID/Nigeria has engaged the MEL Support Activity to evaluate the Drug Revolving Fund (DRF) Activity to determine whether it meets its stated objectives. The evaluation will ascertain if the assistance provided by USAID/Nigeria through the Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project on DRF Activity achieved the stated development objectives (DO). The evaluation also seeks to understand the lessons learned from this Activity in Nigeria.
The purpose is to evaluate the effectiveness, promote accountability, inform decision-making, and ensure the program's sustainability and impact on improving access to essential medicines and healthcare services and to inform USAID/Nigeria’s potential future support for drug revolving funds. The study will provide specific insights into the following proposed states:
About DRF: The drug revolving fund (DRF) is a financing mechanism used in healthcare to improve access to essential drugs and medicines. The primary goal of a DRF is to ensure a steady supply of quality medications and to prevent stock outs or shortages in public health facilities, such as hospitals and health centers. The purpose of the DRF is as follows:
USAID expected the DRF support to achieve the following high-level results:
The primary users of the evaluation findings will be the USAID Health Population and Nutrition (HPN) Office, other U.S. Government (USG) officials, non-USG donor organizations, GON, and private sector firms, all of whom can use the findings to improve and build knowledge. The result of this evaluation will be used by the Mission, GON, implementing partners, and other stakeholders to enhance accountability and learning and to inform decisions on further investment and whether or not the DRF is being re-capitalized. The estimated start date will be July 24, 2024. The evaluation is expected to last until November 2024. Candidates are reviewed on a rolling basis; early submission is recommended.
Position Description: Navanti is seeking a subject matter (Malaria and MNCH) expert to support the team lead in developing context-specific tools for engaging various stakeholders, providing context to the evaluation, and supporting the development of the report. The subject matter expert will work with the team leader to conduct interviews, analyze the data, and develop the evaluation report responsible for the overall coordination and management of the evaluation team’s effort and for ensuring a rigorous and high-quality evaluation in the locations stated above. Under the guidance of the MEL Support Activity, the subject matter expert is expected to work closely with the USAID/Nigeria-HPN team. The team will use a combination of literature review, secondary analysis of population-based surveys, and quantitative/qualitative data collection through focus group discussions and in-depth interviews to gather insights to answer the study questions, with a special focus on data from the four states listed above. The team is also expected to propose based evaluation methodology/approach as required.
Locations:
Responsibilities: The subject matter expert will be responsible for identifying key stakeholders and developing and reviewing data collection tools based on the objective of the evaluation. S/he will be responsible for providing direct technical assistance to the team leader on key strategies to engage targeted stakeholders in conducting the evaluation. The subject matter expert will:
Qualifications: The candidate is expected to have the following qualifications:
The consultant should adhere to ethical guidelines, obtain informed consent, and protect the confidentiality and anonymity of participants.
Only selected candidates will be contacted for an interview. Please, no phone calls.
|